EVGN - צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים Evogene, Ltd.

The stability of Evogene Ltd. (EVGN) is underscored by the implementation of AI modules and accounting automation, as shown on this quarterly earnings per share chart provided by the GURU.Markets platform, where 76.90 reflects the latest metric value. Revenues are based on the MicroBoost AI platform and licensing. Leadership in bio-research enables the company to command high royalty rates for accelerating product development.

The dynamics of quarterly EPS fluctuations reflect the percentage change in earnings per share compared to the same period last year, allowing for an assessment of business scaling rates and cash flow predictability. For Evogene Ltd. (EVGN), this indicator demonstrates how regular licensing revenues and grants offset computational biology costs, confirming financial stability and the absence of cash flow gaps.